Nexium 40 mg enterotabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nexium 40 mg enterotabletter

grünenthal gmbh - esomeprazolemagnesiumtrihydrat - enterotabletter - 40 mg

Nexium 40 mg enterotabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nexium 40 mg enterotabletter

orifarm a/s - esomeprazolemagnesiumtrihydrat - enterotabletter - 40 mg

Nexium 40 mg enterotabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nexium 40 mg enterotabletter

chemvet pharma aps - esomeprazolemagnesiumtrihydrat - enterotabletter - 40 mg

Nexium 40 mg pulver til injektions-/infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nexium 40 mg pulver til injektions-/infusionsvæske, opløsning

grünenthal gmbh - esomeprazolnatrium - pulver til injektions-/infusionsvæske, opløsning - 40 mg

Ulcerex 20 mg enterokapsler, hårde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ulcerex 20 mg enterokapsler, hårde

aristo pharma gmbh - esomeprazolmagnesiumdihydrat - enterokapsler, hårde - 20 mg

Inexium 10 mg enterogranulat til oral suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

inexium 10 mg enterogranulat til oral suspension

nordic prime aps - esomeprazolemagnesiumtrihydrat - enterogranulat til oral suspension - 10 mg

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Den Europæiske Union - dansk - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - clopidogrelhydrochlorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotiske midler - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Esodec 20 mg enterokapsler, hårde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

esodec 20 mg enterokapsler, hårde

krka d.d. novo mesto - esomeprazolmagnesium - enterokapsler, hårde - 20 mg

Esodec 40 mg enterokapsler, hårde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

esodec 40 mg enterokapsler, hårde

krka d.d. novo mesto - esomeprazolmagnesium - enterokapsler, hårde - 40 mg

Esomel 20 mg enterokapsler, hårde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

esomel 20 mg enterokapsler, hårde

krka d.d. novo mesto - esomeprazolmagnesium - enterokapsler, hårde - 20 mg